STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #2690 by analyst upside · 2026-06-27
GDRX
GoodRx Holdings, Inc.
Healthcare · Market Cap $948M · P/E 46.7x
ANALYST PRICE TARGET
+13.6%
implied upside to consensus target
Current Price $2.8
Consensus Target $3.18
Bull Target $4.0
Bear Target $2.25
Analysts Covering 13
ANALYST CONSENSUS - HOLD
Strong Buy
1
Buy
3
Hold
7
Sell
2
52-Week Low $1.77
52-Week High $5.81
YTD Return +1.8%
FUNDAMENTALS
Market Cap $948M
P/E Ratio (TTM) 46.7x
Forward P/E 7.8x
EPS (TTM) $0.06
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $788M
Profit Margin 2.6%
52-WEEK RANGE
52-Week Low $1.77
52-Week High $5.81
Current Price $2.8
Bear Target $2.25
Bull Target $4.0
● Now $2.8 ● Target $3.18
TRADING DATA
Avg Volume 1.5M
YTD Return +1.8%
Analyst Count 13
Consensus Hold
Upside to Target +13.6%
Last Updated 2026-06-27

ANALYST SUMMARY

GoodRx Holdings, Inc. (GDRX) is currently trading at $2.8 with a Wall Street consensus price target of $3.18, implying potential upside of 13.6% over the next 12 months. 13 analysts currently cover GDRX, with a consensus rating of Hold - 31% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $4.0, while the most cautious has a target of $2.25.

GDRX operates in the Healthcare sector with a market capitalisation of $948M. The stock is up 1.8% year-to-date and is currently trading near the lower end of its 52-week range of $1.77 – $5.81.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for GDRX, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Citigroup — Reiterated
Buy → Buy 2026-05-14 Building track record
TD Cowen — Reiterated
Buy → Buy 2026-05-11 Building track record
Wells Fargo — Reiterated
Overweight → Overweight 2026-03-04 Building track record
Citigroup — Reiterated
Buy → Buy 2026-03-03 Building track record
Goldman Sachs — Reiterated
Neutral → Neutral 2026-03-02 Building track record
Mizuho — Reiterated
Neutral → Neutral 2026-02-27 Building track record
JP Morgan ↓ Downgrade
Overweight → Neutral 2026-02-27 43% win rate (7 calls)
Jefferies ↓ Downgrade
Buy → Hold 2026-01-22 50% win rate (6 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
40
out of 100
Coverage depth
20/30
Consensus clarity
18/30
Vote unanimity
0/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →